Clinical Trial Update: The MAP Study: Fluocinolone Acetonide (FA)/Medidur (TM) for Age Related Macular Degeneration (AMD) Pilot [Phase 2]

View source ↗

Summary

This entry notes the completion of a Phase 2 pilot trial evaluating fluocinolone acetonide (Medidur) for age-related macular degeneration, with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Fluocinolone acetonide (fluocinolone acetonide)
• Medidur

Snippet

Sponsor: Johns Hopkins University | Conditions: Age Related Macular Degeneration | Phase 2 | Status: COMPLETED | Results posted: 2014-04-07